Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series: World’s leading Event Organizer
As per available reports about 2 relevant Journals, 12 Conferences, 9 National symposiums are presently dedicated exclusively to tetralogy of fallot and about 11 articles are being published on tetralogy of fallot.
Tetralogy of Fallot (TOF) is a cardiac anomaly that refers to a combination of four related heart defects that commonly occur together. The four defects are:
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and importance:
It is one of the most common congenital heart disorders, comprises right ventricular (RV) outflow tract obstruction (RVOTO) (infundibula stenosis), ventricular septal defect (VSD), aorta dextroposition, and RV hypertrophy. The mortality rate in untreated patients reaches 50% by age 6 years, but in the present era of cardiac surgery, children with simple forms of tetralogy of Fallot enjoy good long-term survival with an excellent quality of life.
Tetralogy of Fallot is the most common form of cyanotic congenital heart disease and accounts for 10% of all congenital heart defects. Corrective surgery has dramatically improved long-term prognosis, with nearly 90% of patients now surviving well into adulthood. Aortic root dilation is a well-recognized feature of unrepaired tetralogy of Fallot, and is increasingly reported in patients, years after corrective surgery. Over the past few decades, the diagnosis and treatment of tetralogy of Fallot have greatly improved. Most children who have this heart defect survive to adulthood. However, they'll need lifelong medical care from specialists to help them stay as healthy as possible. Tetralogy of Fallot (TOF) with absent pulmonary valve syndrome (APVS) usually causes substantial respiratory symptoms, due to bronchial narrowing of severely dilated pulmonary arteries (PAs). A vascular ring, if present, adds more problems. Tetralogy of Fallot with APVS is almost always associated with an absent ductus arteriosus (DA). Right aortic arch with a retroesophageal left subclavian artery (LSA) typically constitutes a vascular ring when a left DA and The absence of the ductus arteriosus have a role in the pathogenesis of tetralogy of Fallot with absent pulmonary valve syndrome. The absence of a ductus arteriosus in the right aortic arch with retroesophageal left subclavian artery precludes a vascular ring. The objective of this contemporary review is to address the scope of the problem regarding aortic dilation in tetralogy of Fallot , explore potential pathophysiological mechanisms, summarize current knowledge regarding adverse events and discuss potential therapeutic options.
Tetralogy of Fallot Global Clinical Trials Review, H2, 2013" provides data on the Tetralogy Of Fallot clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tetralogy Of Fallot. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. Preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tetralogy Of Fallot. Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations. There is considerable scientific evidence that specific interventions will reduce the risk of further vascular events in patients with heart diseases and stroke. If these interventions are appropriately implemented, nearly one third of the fatal and non-fatal MI and strokes could be prevented.
1. 6th Clinical Cardiology Conference November 30-December 02, 2015 San Antonio, USA
2. 7th Cardiothoracic Conference March 29-30, 2016 Atlanta, USA
3. 8th Cardiologists Conference July 18-20, 2016 Berlin, Germany
4. Cardiac Nursing Conference May 5-7, 2016 Chicago, USA
5. 2nd Pediatric Cardiology Conference September 22-24, 2016, Las Vegas, USA
6. Transplantation Conference March 28-29, 2016 Atlanta, USA
7. 4th Healthcare Conference July 18-20, 2016 Brisbane, Australia
8. Healthcare Conference November 09-11, 2015 Dubai, UAE
9. 2nd Hospice and Palliative Care Conference August 25-27, 2016 Philadelphia, USA
10. 6th Healthcare and Fitness Conference August 22-24, 2016 Philadelphia, USA
11. Healthcare Conference October 05-07, 2015 New Delhi, India
12. Hypertension Conference, Aug 4-6, 2016, Toronto, Canada
13. 10th Interventional Cardiology Conference, Sept 12-14, 2016, Berlin, Germany
14. Cardiovascular Imaging Conference, Nov 7-9, 2016, Istanbul, Turkey
15. Angiology Conference Dec 8-10, 2016,San Antonio, USA
16. Internal Medicine Conference, November 03-05, 2016 Baltimore, Maryland, USA
17. Anesthesia and Intensive Care conference September 12-14, 2016 Phoenix, Arizona, USA
18. 4th Surgery Conference October 05-07, 2015 Crowne Plaza, Dubai, UAE
19. 5th Surgery Conference October 06-08, 2016 Alicante, Spain
20. 2nd Pain Medicine Conference May 16-18, 2016 San Antonio, USA
21. Hospice and Palliative Care Conference August 31-September 02, 2015 Orlando, USA
22. Challenges in Clinical Cardiology, September 18-20 2015 Atlanta, USA
23. 16th Annual Intensive Review of Cardiology, August 23-26, 2015 Ohio, USA
24. The 20th Annual Scientific Session of the American Society of Nuclear Cardiology, September 17-20,2015 Washington, USA
Relevant Society and Associations
1. Society of Thoracic Surgeons
2. Georgian Society of Cardiology
3. Heart of Georgia Cardiology
4. West Georgia Cardiology
5. East Georgia Cardiology-
6. European Society of Cardiology
7. European Heart Rhythm Associatio
8. European Society for Cardio-Vascular Surgery
9. European Association of Cardiothoracic Anaesthesiologists (EACTA)
10. French Society of Cardiology
11. Swiss Society of Cardiology
12. Italian Society of Cardiology
13. Hungarian Society of Cardiology
14. The American Heart Association
15. Heart Failure Society of America
16. Society of Invasive Cardiovascular Professionals
17. European Society of Cardiology
18. American Society of Preventive Cardiology
19. European Heart Rhythm Association
20. European Society for Cardio-Vascular Surgery
21. European Association of Cardiothoracic Anaesthesiologists (EACTA)
22. French Society of Cardiology
23. American Association of Heart Failure Nurses
24. Heart Failure Society of America
2. Angel Medical Systems
3. Topera Medical
4. Lombard Medical Technologies Plc
5. AtriCure, Inc.
6. Sorin S.p.A.
7. SurModics, Inc.
8. Cook Medical Incorporated
12. Care stream Health
14. Keystone Medical Technologies
16. Boehringer Ingelheim
18. Cerevast Therapeutics
19. Paragon Medical
21. Apaxis Medical
22. Paragon Medical
This page will be updated regularly.
This page was last updated on 14th Sep, 2015
1-702-508-5200 Ext:8031, 8041
1-702-508-5200 Ext:8045, 8047
Immunology & Microbiology Conferences
Nursing and Healthcare Conferences
Clinical and Biochemistry Conferences
1-702-508-5200 Ext:8031, 8037
Material Science Conferences
Genetics & Mol Biology Conferences
Media Partners | Advertising